Navigation Links
Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
Date:8/17/2010

MARLBOROUGH, Mass., Aug. 17 /PRNewswire/ -- Block Engineering, a leading developer of mid-infrared spectroscopy sensors, announced today the launch of a family of next-generation, revolutionary spectrometers based on widely tunable quantum cascade lasers (QCLs). Daniel Cavicchio, chairman of Block Engineering, commented, "This announcement is a significant milestone in Block's history and it is the result of a multiyear focused development effort, which was supported by significant government and internal funding. Our customers have received these products very well and we look forward to strong growth over the next few years."

"The applications of QCLs are so broad that we have attracted strong interest from both commercial and government customers," said Adam Erlich, VP of Marketing and Business Development of Block Engineering. "This is the reason for introducing three products at the onset: LaserScan™, which can analyze surface chemistries from a distance of 6 inches to 2 feet; LaserScope™, which is a high-performance IR microscope; and LaserTune™, which is a tunable QCL source used by researchers. Because all these products have enhanced performance versus traditional Fourier Transformed Infrared (FTIR) spectrometers, we are experiencing huge interest among military users, life science researchers, pharmaceutical/chemical companies, plastic products manufacturers and environmental firms."

Petros Kotidis, CEO of Block Engineering, commented, "Block's staff has unique, deep knowledge of spectroscopy, rugged packaging, signal processing and decades of experience in new product introduction for both commercial and government markets. These new products have been developed in record time and I am very pleased to see that we are meeting and exceeding our customers' needs in our new and exciting target markets."

These products will be showcased at the American Chemical Society Exposition in Boston on August 22-26, 2010.

About Block Engineering:

Founded in 1956, Block Engineering is a leading developer of high performance QCL and FT-IR spectrometers for chemical detection and analysis to military, government, commercial, and industrial customers. Its Mobile Chemical Agent Detector (MCAD) system, in partnership with Northrop Grumman Corporation, and, PORTHOS™, a portable FT-IR spectrometer system, remotely detect chemical threats as far as 3 miles and protect against chemical warfare agents and weapons of mass destruction. Following this success, Block has applied its extensive knowledge of spectroscopy and chemical detection towards the commercialization of its high performance QCL based spectrometers. In addition, Block is developing a revolutionary MEMS-based, miniaturized spectrometer, the ChemPen™, which is a low cost, FTIR chemical gas detector the size of a fountain pen.

Block Engineering is headquartered in Marlborough, Massachusetts, USA. For more information, visit www.blockeng.com.

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.


'/>"/>
SOURCE Block Engineering
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amedica® Receives Patent for Hip Implant Using Monoblock Ceramic Technology
2. Frost & Sullivan Recognizes Timoptic(R) (timolol maleate) as Best Brand Name Beta Blocker for Glaucoma: Timoptic Brand is Highest Rated in Survey of Ophthalmologists
3. CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
4. Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market
5. BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
6. Four Basics and Some Good Information About Beta-Blocker Treatment for High Blood Pressure
7. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
8. Study Shows Leconotide, an Investigative Calcium Channel Blocker, Has Potential as a Selective, Efficacious, Non-Opioid Pain Treatment
9. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
10. SF1126, Semafores PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines
11. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/4/2017)... OBP Medical , a leading ... today announced regulatory approval from Brazil,s ... Nacional de Vigilância Sanitária (ANVISA)) to market ... with integrated LED light source and smoke evacuation ... of a tissue pocket or cavity during surgical ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):